Authors: Dette, Holger
Kettelhake, Katrin
Schorning, Kirsten
Wong, Weng Kee
Bretz, Frank
Title: Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Language (ISO): en
Abstract: Nonlinear regression models addressing both efficacy and toxicity outcomes are increasingly used in dose-finding trials, such as in pharmaceutical drug development. However, research on related experimental design problems for corresponding active controlled trials is still scarce. In this paper we derive optimal designs to estimate efficacy and toxicity in an active controlled clinical dose finding trial when the bivariate continuous outcomes are modeled either by polynomials up to degree 2, the Michaelis- Menten model, the Emax model, or a combination thereof. We determine upper bounds on the number of different doses levels required for the optimal design and provide conditions under which the boundary points of the design space are included in the optimal design. We also provide an analytical description of the minimally supported D-optimal designs and show that they do not depend on the correlation between the bivariate outcomes. We illustrate the proposed methods with numerical examples and demonstrate the advantages of the D-optimal design for a trial, which has recently been considered in the literature.
Subject Headings: Active controlled trials
Tchebycheff system
Particle swarm optimization
Equivalence theorem
Emax model
admissible design
optimal design
dose finding
Issue Date: 2016
Appears in Collections:Sonderforschungsbereich (SFB) 823

Files in This Item:
File Description SizeFormat 
DP_0116_SFB823_Dette_Kettelhake_Schorning_Wong_Bretz.pdfDNB1.56 MBAdobe PDFView/Open

This item is protected by original copyright

Items in Eldorado are protected by copyright, with all rights reserved, unless otherwise indicated.